Outpatient Treatment of Antibiotic-Resistant Soft Tissue Infections
Initial Management Approach
- The Infectious Diseases Society of America recommends incision and drainage as the primary treatment for abscesses, with oral TMP-SMX, doxycycline, or clindamycin as first-line antibiotic options for 5-10 days 1, 2
- Incision and drainage is the cornerstone of therapy for purulent infections, and may be adequate alone for simple abscesses without systemic features 1
- Antibiotics should be added when there are multiple sites of infection, rapid progression with associated cellulitis, signs of systemic illness, comorbidities, extremes of age, or abscesses in difficult-to-drain locations 1
First-Line Oral Antibiotic Options
- The American College of Physicians recommends TMP-SMX dosing at 1-2 double-strength tablets twice daily, with a duration of 5-10 days for uncomplicated infections 1, 2
- Doxycycline dosing is recommended at 100 mg twice daily, with a duration of 5-10 days 1, 2
- Clindamycin dosing is recommended at 300-450 mg three times daily, with a duration of 5-10 days 1, 2
Coverage for Beta-Hemolytic Streptococci
- The Infectious Diseases Society of America recommends empiric coverage for beta-hemolytic streptococci for nonpurulent cellulitis, using beta-lactam antibiotics as first-line treatment 1
Treatment Duration and Monitoring
- The standard duration of treatment is 5-10 days for uncomplicated outpatient infections 2
- Clinical response should be evident within 48-72 hours, and if no improvement is seen, reassessment and consideration of alternative diagnoses or resistant organisms is necessary 1, 3
Special Populations
- For pediatric patients, TMP-SMX dosing is recommended at 4-6 mg/kg/dose twice daily, doxycycline dosing is recommended at 2 mg/kg/dose twice daily, and clindamycin dosing is recommended at 10-13 mg/kg/dose three times daily 1, 2, 3
- For pregnant patients, clindamycin is preferred if antibiotic treatment is necessary, and TMP-SMX and tetracyclines should be avoided 1, 4
Concurrent Use of Bactrim DS and Doxycycline
Clinical Rationale for Concurrent Use
- The Infectious Diseases Society of America recommends both TMP-SMX (160-320/800-1600 mg PO q12h) and doxycycline (100 mg PO q12h) as equivalent first-line options for outpatient treatment of purulent skin and soft tissue infections, with treatment duration of 5-10 days 5, 6, 7, 8
Practical Management Algorithm
- If antibiotics are indicated for a skin abscess, the American College of Clinical Pharmacy suggests proceeding with antibiotic selection, and switching from Bactrim DS to doxycycline monotherapy may be a preferred approach if the UTI treatment course is nearly complete 5
- The Infectious Diseases Society of America implies that continuing Bactrim DS and adding doxycycline may be an alternative approach only if the UTI requires completion of the full TMP-SMX course and the abscess requires immediate additional coverage 5